February 24th 2025
The FDA has authorized key modifications to the administration protocol for injectable long-acting opioid use disorder treatment buprenorphine.
Reducing Opioid-Involved Overdose Deaths: States’ Prevention and Response Efforts
August 19th 2021In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.
Read More